Replace Your FibroScan: A Practical Trade-In Pathway
For Australian clinics with an existing FibroScan and growing reasons to switch — here's how to handle the transition without disrupting patient care.
Why Practices Are Looking to Switch
FibroScan has been the dominant liver elastography device in Australia for over a decade. Practices that bought in early have generated significant clinical and commercial value from their units. But four pressures are now compounding for current FibroScan owners:
- MSAC 1797 rejection (2025): standalone FibroScan/VCTE has no Medicare rebate pathway. Patient scans remain 100% out-of-pocket at $250–$330.
- Annual service contracts (~$11,400/year): a fixed cost independent of scan volume. The contract compounds the TCO problem and is non-negotiable from Echosens.
- XL probe requirement for high-BMI cohorts: the standard M probe fails in 20–25% of patients with BMI >30. The XL probe is a $3,800+ AUD additional capital item that still doesn't eliminate failure.
- Single-purpose hardware: the device can only perform VCTE. Idle FibroScans accumulate service costs without revenue capacity in other modalities.
The Practical Switching Path
Replacing a FibroScan is straightforward when you know the moving parts. The transition typically takes 4–8 weeks from initial conversation to full clinical use of the replacement system. The key steps:
1. Audit your existing FibroScan position
Three numbers determine your starting point: the residual book value of your existing unit, the remaining months on your service contract, and your weekly scan volume. These three numbers feed directly into the breakeven calculation for switching.
2. Decide what to do with the existing unit
Three options: trade-in (we can assess), sell privately (secondary market exists but is small in Australia), or retain as a backup unit during transition. Most practices opt for a structured handover rather than running both systems concurrently.
3. Plan the data continuity
Historical FibroScan reports are valid clinical records and don't need to be migrated. New scans on the replacement system reference the FibroScan baseline directly in the clinical narrative. The kPa unit is identical between systems; the steatosis grade scale (S0–S3) is identical even though FibroScan uses CAP and iLivTouch uses UAP for the raw measurement.
4. Train the clinical team
Experienced FibroScan operators usually adapt to iLivTouch within 1–2 days of structured training. The main change is moving from blind VCTE acquisition to guided 2D-SWE — most operators find the guided workflow more intuitive. Full clinical workflow integration takes 2–4 weeks of routine use.
5. Communicate with referring clinicians
Referring GPs and specialists should be notified that scans will continue under the same clinical service but on a different device. Most referring clinicians don't need the technical details — they care about the kPa result, the reliability, and the reporting format. Keeping report templates consistent across the transition removes any friction.
What the Math Usually Looks Like
For a typical practice running 10–15 FibroScan scans per week with 2 years left on a service contract: switching to a guided 2D-SWE system at ~$70,000 AUD typically reaches breakeven in 12–18 months after factoring in eliminated service contract costs, retained scan revenue, and new abdominal ultrasound billing capacity unlocked by the multi-modality device.
Higher scan volumes shorten the payback. Lower volumes lengthen it. The single biggest variable is whether the practice can use the new system's additional billing capacity — for imaging centres and clinics doing other ultrasound work, this is the swing factor.
What to send us for an indicative trade-in assessment
- Existing FibroScan model (502 / 530 / 630 Expert) and year of purchase
- Service contract end date and remaining contract value
- Probes owned (M, XL, paediatric)
- Approximate weekly scan volume and patient BMI mix
- Whether the practice has other ultrasound capability today
Frequently Asked Questions
Can I trade in my existing FibroScan?
Elastography Australia works with practices replacing existing FibroScan units. Trade-in arrangements are evaluated case-by-case based on the model, age, condition, and remaining service contract obligations. Contact us with your unit details (model number, year of purchase, service contract status) and we'll quote a switching pathway.
What happens to my historical FibroScan patient data?
Historical FibroScan kPa and CAP measurements remain valid clinical records and continue to be useful for trend tracking even after switching devices. iLivTouch reports use the same kPa unit for liver stiffness and produce comparable S0–S3 steatosis grades (using UAP rather than CAP, but the grade scale is the same). Patient follow-up scans on iLivTouch can reference prior FibroScan baselines.
Do I need to wait for my Echosens service contract to end?
Service contract end dates affect the commercial math but don't prevent switching. Many practices switch mid-contract — the question becomes whether the ongoing service fees ($11,400+/year typical) outweigh the benefit of moving sooner. We work with practices to model the breakeven date based on remaining contract value vs new system benefits.
How long does training take when switching from FibroScan to iLivTouch?
Experienced FibroScan operators typically transition to iLivTouch within 1–2 days of structured training. The core liver stiffness concept is identical (kPa measurement) — the main change is the guided acquisition workflow, which most operators find more intuitive than blind VCTE. Full clinical workflow integration usually takes 2–4 weeks of routine use.
Why are practices replacing FibroScan in Australia?
The main drivers are: (1) MSAC 1797 rejection in early 2025 means FibroScan-only services have no Medicare rebate pathway, (2) the $11,400/year service contract cost compounds over time and is independent of scan volume, (3) failure rates in higher-BMI patients require XL probe purchases, and (4) the device is single-purpose — it cannot bill for any other modality. Guided 2D-SWE systems address all four pressures in a single replacement.
Start the trade-in conversation
Send us your existing FibroScan details and we'll model the switching economics for your practice. No commitment required.
Contact us about trade-in